drug

lonapegsomatropin-tcgd

1 story · latest Aug 13, 2026

Status: FDA approved Aug 2021 · BLA761177
Brand: Skytrofa
Trials: 1 registered trial in coverage

Also known as

lonapegsomatropin

Timeline

Ascendis Pharma posts Q2 2026 revenue of €315 million, up 105% year over year

Aug 13Clinical readoutAscendis Pharma A/S navepegritide

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.